Mark Pruzanski Intercept Pharmaceuticals, Inc. (ICPT) insider trading activity

ICPT Quotes by TradingView

Mark Pruzanski is Director of INTERCEPT PHARMACEUTICALS, INC.. Currently has a direct ownership of 0 shares of ICPT, which is worth approximately $0. The most recent transaction as insider was on Dec 31, 2020, when has been sold 41,236 shares (Common Stock) at a price of $24.7 per share, resulting in proceeds of $1,018,529. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Mark Pruzanski Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 31 2020
BUY
Grant, award, or other acquisition
$1,018,529 $24.7 p/Share
41,236 Added 7.39%
516,753 Common Stock
Oct 01 2020
SELL
Payment of exercise price or tax liability
$32,486 $42.08 p/Share
772 Reduced 0.16%
475,517 Common Stock

Also insider at

EQ
Equillium, Inc. Healthcare
MP

Mark Pruzanski

Director
New York, NY

Track Institutional and Insider Activities on ICPT

Follow INTERCEPT PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ICPT shares.

Notify only if

Insider Trading

Get notified when an Intercept Pharmaceuticals, Inc. insider buys or sells ICPT shares.

Notify only if

News

Receive news related to INTERCEPT PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ICPT